Encorium reported financial results for the quarter. Revenues rose 8 percent, to $8.9 million. But the company’s loss increased by 200 percent, to $3.8 million. The company’s new CEO, David Ginsberg, is optimistic about European projects and the future: “Recent new business wins include contracts in the therapeutic arena of oncology, which is a recent focus for…more...